The benefits of ribose in cardiovascular disease

• Published in: Medical hypotheses Vol. 60; no. 2; pp. 149 - 151
• Main Authors: Pauly, D.F., Johnson, C., St.Cyr, J.A.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Ltd 01.02.2003
• Subjects: Animals; Cardiovascular Diseases - drug therapy; Humans; Myocardium - metabolism; Ribose - therapeutic use
• ISSN: 0306-9877; 1532-2777
• DOI: 10.1016/S0306-9877(02)00165-2

Cardiovascular disease still ranks as the leading cause of death in men and women. Adults have tried to lower their risk of cardiovascular disease by improving their diet, quitting smoking, controlling blood pressure and exercising regularly. Additionally, many adults have turned to nutriceutical or natural products. Myocardial ischemia, produces a depression in myocardial tissue levels of high energy compounds, along with a compromise in myocardial function. Ribose, a naturally occurring sugar, has been extensively investigated, both in animal and clinical studies, as an agent to enhance the recovery of these depressed energy compounds. Results of these studies have been promising in enhancing the recovery of these energy molecules along with an improvement in myocardial function. Therefore, ribose should be considered as a potential agent in the treatment of ischemic cardiovascular disease.